I
Imke Metz
Researcher at University of Göttingen
Publications - 81
Citations - 4415
Imke Metz is an academic researcher from University of Göttingen. The author has contributed to research in topics: Multiple sclerosis & Natalizumab. The author has an hindex of 31, co-authored 75 publications receiving 3552 citations.
Papers
More filters
Journal ArticleDOI
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Sven Jarius,Klemens Ruprecht,Brigitte Wildemann,Tania Kuempfel,Marius Ringelstein,Christian Geis,Ingo Kleiter,Ingo Kleiter,Christoph Kleinschnitz,Achim Berthele,Johannes Brettschneider,Kerstin Hellwig,Bernhard Hemmer,Ralf A. Linker,Ralf A. Linker,Florian Lauda,Christoph Mayer,Hayrettin Tumani,Arthur Melms,Corinna Trebst,Martin Stangel,Martin Marziniak,Frank Hoffmann,Sven Schippling,Jürgen H. Faiss,Oliver Neuhaus,Barbara Ettrich,Christian Zentner,Kersten Guthke,Ulrich Hofstadt-van Oy,Reinhard Reuss,Hannah L. Pellkofer,Ulf Ziemann,Peter Kern,Klaus Peter Wandinger,Florian Then Bergh,Tobias Boettcher,Stefan Langel,Martin Liebetrau,Paulus S. Rommer,Sabine Niehaus,Christoph Münch,Alexander Winkelmann,Uwe K Zettl U,Imke Metz,Christian Veauthier,Jörn P Sieb,C. Wilke,Hans Hartung,Orhan Aktas,Friedemann Paul +50 more
TL;DR: This study provides an overview of the clinical and paraclinical features of NMOSD in Caucasians and demonstrates a number of distinct disease characteristics in seropositive and seronegative patients.
Journal ArticleDOI
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.
Josa M. Frischer,Stephen D. Weigand,Yong Guo,Nilufer Kale,Joseph E. Parisi,Istvan Pirko,Jay Mandrekar,Stephan Bramow,Imke Metz,Wolfgang Brück,Hans Lassmann,Claudia F. Lucchinetti +11 more
TL;DR: An extensive analysis of white matter plaques in a large sample of multiple sclerosis autopsies provides insights into the dynamic nature of MS pathology.
Journal ArticleDOI
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis
Claudia F. Lucchinetti,R. H. Gavrilova,Imke Metz,Joseph E. Parisi,B. W. Scheithauer,S. Weigand,K. Thomsen,Jay Mandrekar,Ayse Altintas,Bradley J. Erickson,F. König,C. Giannini,Hans Lassmann,L. Linbo,S. J. Pittock,Wolfgang Brück +15 more
TL;DR: Although lesion size >5 cm was associated with a slightly higher EDSS at last follow-up, long-term prognosis in patients with disease duration >10 years was better compared with a population-based multiple sclerosis cohort matched for disease duration (EDSS 3.5; P < 0.001).
Journal ArticleDOI
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
Melania Spadaro,Lisa Ann Gerdes,Markus Krumbholz,Birgit Ertl-Wagner,Franziska S. Thaler,Elisabeth Schuh,Imke Metz,Astrid Blaschek,Andrea Dick,Wolfgang Brück,Reinhard Hohlfeld,Edgar Meinl,Tania Kümpfel +12 more
TL;DR: Antibodies to MOG can be found in a distinct subgroup of adult patients with clinically definite multiple sclerosis with a specific clinical phenotype and may indicate disease heterogeneity.
Journal ArticleDOI
Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons
Shailender Singh,Shailender Singh,Imke Metz,Sandra Amor,Sandra Amor,Paul van der Valk,Christine Stadelmann,Wolfgang Brück +7 more
TL;DR: The data demonstrate that the occurrence of microglial nodules is not specific to MS and is associated with degenerating as well as damaged axons in early MS, and show that early MS microglia/macrophages exhibit both pro- and antiinflammatory phenotypes.